HBB rs886043558: Understanding This Genetic Variant
The rs886043558 variant is located within the HBB gene, which provides instructions for making a protein essential for oxygen transport in the blood. This specific variant is linked to sickle cell trait and related hemoglobin disorders, necessitating clinical validation to determine individual carrier status.
What each genotype means
Heterozygous carrier status
You carry one copy of the AT insertion variant at this position. This specific variant is associated with Zellweger syndrome in clinical databases, which is distinct from sickle cell trait; please consult with a medical geneticist or clinician to discuss the clinical relevance of this finding for your health.
This genotype is rare and typically identified in clinical settings rather than general population screening.
Homozygous variant status
You carry two copies of the AT insertion variant at this position. This genotype is documented in clinical databases as pathogenic for Zellweger syndrome, a condition that requires professional medical evaluation and genetic counseling.
This genotype is extremely rare in the general population.
What is the rs886043558 Variant?
The rs886043558 variant is a specific change in the DNA sequence of the HBB gene. In genomics, a variant like this represents a difference in the genetic code compared to the most common sequence found in the human population. Because the HBB gene is responsible for producing the beta-globin subunit of hemoglobin, changes in this region can potentially alter the structure or production levels of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This variant is categorized as a trait-associated marker, meaning researchers have observed statistical links between this genetic change and specific health-related characteristics. However, the presence of a variant does not automatically imply a health condition; it serves as a piece of information that may require further investigation by medical professionals to understand its specific impact on an individual's physiology.
The Role of the HBB Gene
The HBB gene, located on chromosome 11, is fundamental to human health because it encodes the beta-globin protein. Adult hemoglobin is a complex molecule typically composed of two alpha-globin chains and two beta-globin chains. This structure allows hemoglobin to bind oxygen in the lungs and release it into tissues throughout the body. When the HBB gene functions normally, it ensures the production of stable, efficient hemoglobin. When variants occur within this gene, they can lead to a variety of outcomes. Some variants are benign and have no effect on health, while others can disrupt the production of beta-globin, leading to conditions such as beta-thalassemia, where hemoglobin production is reduced, or sickle cell disease, where the hemoglobin structure is altered, causing red blood cells to become rigid and misshapen. Understanding the HBB gene is crucial for identifying the root causes of various inherited blood disorders.
Research and Clinical Evidence
Scientific research has established a strong link between the HBB gene and hemoglobin-related disorders. The evidence for the association between HBB variants and conditions like sickle cell disease is well-documented through clinical studies and genetic databases. For rs886043558 specifically, the evidence strength is currently considered moderate. This means that while there is a documented association with sickle cell trait and related hemoglobin disorders, the clinical implications for any single individual carrying this variant may vary. Research often relies on case-level data and experimental studies to determine how a specific variant affects hemoglobin polymerization or stability. Because the HBB gene is highly polymorphic—meaning it has many different variants—the clinical significance of any one variant depends on its specific effect on the protein. Consequently, clinical validation is essential to interpret what this variant means for a person's health, as it may interact with other genetic factors.
Population Frequency and Interpretation
The rs886043558 variant is classified as rare in the general population. In genetics, a rare variant is one that appears in a very small percentage of individuals across various ancestral groups. Because it is rare, it is not typically found in large-scale population screening studies at high frequencies. When a variant is rare, it can be more challenging for researchers to gather enough data to fully understand its penetrance, or the likelihood that it will cause a specific health outcome. For individuals who receive information about this variant, it is important to recognize that population-level data provides a broad context but cannot predict an individual's specific health status. Genetic information should always be interpreted in the context of a person's family history, clinical symptoms, and professional medical advice. If you have questions about your genetic results, discussing them with a genetic counselor or a healthcare provider is the most appropriate step.
What You Can Do With This Information
Genetic information is a tool for understanding your biological makeup, but it is not a substitute for a medical diagnosis. If you have identified that you carry the rs886043558 variant, the most important action is to consult with a qualified healthcare professional, such as a primary care physician or a genetic counselor. They can help you understand the clinical significance of this finding in the context of your overall health. You should not make any medical decisions, such as starting or stopping medications, based solely on a genetic report. If this variant is associated with medication response, always discuss dosing and treatment plans with your clinician or pharmacist. They are equipped to integrate your genetic data with other clinical information to provide personalized guidance. Remember that genetic testing is a starting point for a conversation about your health, not the final word.
How common is this variant?
The rs886043558 variant is documented as rare across global populations, meaning it is not commonly observed in the general public.
Frequently asked questions
What does it mean to have a rare HBB variant?
Having a rare variant in the HBB gene means that the specific DNA change is not common in the general population. It does not necessarily mean you have a disease, but it may warrant further clinical evaluation to understand its impact on your hemoglobin.
Is rs886043558 the same as sickle cell disease?
No, rs886043558 is a specific genetic variant associated with hemoglobin traits. Sickle cell disease is a complex condition caused by specific changes in the HBB gene, and clinical testing is required to determine if a variant contributes to a specific diagnosis.
Should I be worried if I have this variant?
Genetic variants are common, and many do not cause health issues. You should discuss your results with a healthcare provider who can interpret the findings in the context of your personal and family medical history.
Can I use this information to change my medication?
No. You should never change your medication or treatment plan based on genetic information without consulting your doctor or pharmacist. They are the only ones who can safely adjust your care based on your unique genetic and clinical profile.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs886043558?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a pathogenic mutation in the HBB gene associated with beta-thalassemia.
This variant is a pathogenic mutation in the HBB gene associated with hemoglobinopathies such as sickle cell disease.
This variant (c.20A>T, p.Glu7Val) causes the substitution of valine for glutamic acid in the beta-globin chain, leading to sickle cell trait or disease depending on zygosity.
Pathogenic variant (p.Glu6Val, HbS-Antilles) in HBB associated with sickle cell disease-like pathology.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.